Animal drug shortages limit veterinary therapeutic options and introduce artifacts in antimicrobial sales reporting
Year: 2024
Type: article
Abstract: Supply chain issues disrupt veterinary care and cause downstream consequences that alter the practice of veterinary medicine. Antimicrobials are just 1 class of pharmaceuticals that have been impacted by supply chain issues over the last couple of years. Since February 2021, 2 sponsors/manufacturers of penicillin products have reported shortages in the active pharmaceutical ingredient. With the release of the 2021 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals by the FDA, a key finding was a 19% decrease in penicillin sales and distribution from 2020 to 2021. Herein, we provide our clinicians' professional perspective regarding how drug shortages, specifically that of penicillin, might contribute to misconstrued patterns in antimicrobial use and what can be done by veterinarians and the FDA to minimize the impact of an antimicrobial drug shortage on animal health and well-being.
Authors: _ _, Rebecca C. Robbins, Randall S. Singer, Gabriel K. Innes, Paul J. Plummer, Michael D. Apley, Patricia S. Gaunt, Mark G. Papich, Jennifer Granick, Edith S. Marshall, David R. Smith, Erin Frey, Hector M. Cervantes, Amanda L. Beaudoin, Abbey J. Canon, Cooper Brookshire, Michelle Buckley, Janet Whaley, Lauren Schnabel, Michael Costin
Institution: Mississippi State University
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4390572579